文献速递复苏、休克与脓毒症消化、代谢与肾脏急症重症综合管理与镇静镇痛

迷走神经刺激调节肠缺血再灌注后肠系膜淋巴中花生四烯酸的产生

Vagus nerve stimulation modulates arachidonic acid production in the mesenteric lymph following intestinal ischemia-reperfusion injury.
PubMed 文献 · J Trauma Acute Care Surg · 2021-01-01
一句话结论大鼠实验显示,肠系膜上动脉阻塞前10分钟至阻塞后10分钟进行迷走神经刺激(5 V,0.5 Hz),可减轻肠损伤并抑制肠系膜淋巴中花生四烯酸生成与NF-κB活化。

该研究为雄性Sprague-Dawley大鼠动物实验:开腹行肠系膜上动脉阻塞(SMAO)60分钟诱导肠缺血再灌注,行肠系膜淋巴管插管,采集SMAO前后淋巴样本,观察期末取远端回肠。一组动物在SMAO前10分钟至SMAO后10分钟行VNS(5 V,0.5 Hz)。结果显示,VNS减轻了SMAO所致组织学肠损伤;SMAO后肠系膜淋巴中花生四烯酸浓度与NF-κB活化水平显著升高,而VNS阻止了这些反应;SMAO后淋巴与回肠出现PLA2-IIA表达,VNS组PLA2-IIA条带明显减弱。提示VNS可能通过改变肠道与肠系膜淋巴中PLA2-IIA表达,减少淋巴中花生四烯酸生成、减轻淋巴毒性。

要点

  • 动物实验中,SMAO 60分钟诱导肠缺血再灌注后,肠系膜淋巴花生四烯酸浓度与NF-κB活化水平显著升高。
  • 在SMAO前10分钟至后10分钟行VNS(5 V,0.5 Hz)可阻止上述淋巴花生四烯酸升高与NF-κB活化。
  • VNS减轻SMAO所致组织学肠损伤,并显著减弱肠系膜淋巴与回肠中PLA2-IIA条带。
  • 机制提示VNS通过改变肠道及肠系膜淋巴PLA2-IIA表达,减少淋巴中花生四烯酸产生,可能降低淋巴毒性。
  • 以上均为大鼠实验结论,尚未在急诊或ICU患者中验证,不能直接转化为临床VNS参数推荐。

适用人群与场景

  • 雄性Sprague-Dawley大鼠,开腹行肠系膜上动脉阻塞(SMAO)60分钟诱导肠缺血再灌注,行肠系膜淋巴管插管并采集SMAO前后淋巴样本,观察期末取远端回肠。
  • 原文未提及人类急诊、ICU或院前适用人群,也未给出纳入/排除标准。

诊断标准与关键阈值

  • 肠缺血再灌注模型:开腹后行肠系膜上动脉阻塞(SMAO)持续60分钟,随后再灌注并观察。
  • VNS方案:在SMAO前10分钟至SMAO后10分钟实施,参数为5 V、0.5 Hz。
  • 原文未提及临床诊断标准、评分界值或启动/停止阈值。

处置流程与药物剂量

  • 第一步:开腹行SMAO 60分钟诱导肠缺血,随后再灌注并观察。
  • 第二步:行肠系膜淋巴管插管,分别在SMAO前与SMAO后采集肠系膜淋巴样本。
  • 第三步(干预组):于SMAO前10分钟至SMAO后10分钟行VNS,参数5 V、0.5 Hz。
  • 第四步:对每个淋巴样本行液相色谱-电喷雾电离-串联质谱检测花生四烯酸,并以单核细胞NF-κB活化试验检测淋巴生物活性。
  • 第五步:对淋巴与回肠样本行PLA2-IIA蛋白免疫印迹(Western blot)。
  • 原文未给出人体给药剂量、途径、频次或目标值。

红旗征与不能漏的情况

  • 原文未提及临床红旗征或需立刻处理的情况。

研究设计与关键结果

  • 研究类型:动物实验(大鼠);样本量与中心数原文未提及。
  • 人群/模型:雄性Sprague-Dawley大鼠,SMAO 60分钟诱导肠缺血再灌注。
  • 干预与对照:VNS组在SMAO前10分钟至后10分钟行VNS(5 V,0.5 Hz),与未行VNS的SMAO动物比较。
  • 关键次要终点:SMAO后肠系膜淋巴与回肠出现PLA2-IIA表达,VNS组PLA2-IIA条带显著减弱(原文未给出定量数值)。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠在体实验)。
  • 证据等级或推荐强度:原文未提及。
  • 局限:仅为大鼠SMAO模型,样本量与中心数原文未提及;VNS参数(5 V,0.5 Hz,SMAO前10分钟至后10分钟)为特定实验方案,不能外推为临床推荐;机制结论基于淋巴与回肠PLA2-IIA蛋白印迹及体外NF-κB活化试验,需进一步验证。

对床旁实践的改变

  • 该内容提示:在肠缺血再灌注动物模型中,VNS可减轻肠损伤并降低肠系膜淋巴花生四烯酸与NF-κB活化,为「肠-淋巴途径」调控炎症脂质介质提供实验依据。
  • 目前不改变急诊/ICU床旁做法:尚无人体数据支持在肠缺血、休克或脓毒症患者中使用VNS(5 V,0.5 Hz)或据此调整治疗。
  • 适用与不适用人群:原文仅涉及雄性Sprague-Dawley大鼠SMAO模型,未涉及人类患者,不能据此确定临床适用或排除人群。
  • 常见陷阱:不可将动物实验中的VNS参数(5 V,0.5 Hz、SMAO前10分钟至后10分钟)直接写成临床推荐剂量或方案。

指南或共识出处

  • 原文未提及指南或共识;文献来源为J Trauma Acute Care Surg。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Inflammatory lipid mediators in mesenteric lymph (ML), including arachidonic acid (AA), are considered to play an important role in the pathogenesis of multiple-organ dysfunction after hemorrhagic shock. A previous study suggested that vagus nerve stimulation (VNS) could relieve shock-induced gut injury and abrogate ML toxicity, resulting in the prevention of multiple-organ dysfunction. However, the detailed mechanism of VNS in lymph toxicity remains unclear. The study aimed to investigate the relationship between VNS and inflammatory lipid mediators in ML.

METHODS: Male Sprague-Dawley rats underwent laparotomy and superior mesenteric artery obstruction (SMAO) for 60 minutes to induce intestinal ischemia followed by reperfusion and observation. The ML duct was cannulated, and ML samples were obtained both before and after SMAO. The distal ileum was removed at the end of the observation period. In one group of animals, VNS was performed from 10 minutes before 10 minutes after SMAO (5 V, 0.5 Hz). Liquid chromatography-electrospray ionization-tandem mass spectrometry analysis of AA was performed for each ML sample. The biological activity of ML was examined using a monocyte nuclear factor κ-light-chain-enhancer of activated B cells activation assay. Western blotting of phospholipase A2 group IIA (PLA2-IIA) was also performed for ML and ileum samples.

RESULTS: Vagus nerve stimulation relieved the SMAO-induced histological gut injury. The concentration of AA and level of nuclear factor κ-light-chain-enhancer of activated B cells activation in ML increased significantly after SMAO, whereas VNS prevented these responses. Western blotting showed PLA2-IIA expression in the ML and ileum after SMAO; however, the appearance of PLA2-IIA band was remarkably decreased in the samples from VNS-treated animals.

CONCLUSION: The results suggested that VNS could relieve gut injury induced by SMAO and decrease the production of AA in ML by altering PLA2-IIA expression in the gut and ML.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Nakatsutsumi K, Morishita K, Yagi M, et al. Vagus nerve stimulation modulates arachidonic acid production in the mesenteric lymph following intestinal ischemia-reperfusion injury. J Trauma Acute Care Surg. 2021. PMID: 34238858. doi:10.1097/TA.0000000000003345

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。